Announcements and milestones from miRoncol Health.
miRoncol Health announced a partnership with YEARS, one of Europe’s most advanced preventive clinics, to bring its miCheckUp microRNA screening test to clients in Berlin.
Read More »June 1, 2026
miRoncol's CEO and co-founder Victoria Xu was named one of five recipients of the 2025 City of Ottawa Immigrant Entrepreneur Awards.
Read More »November 7, 2025
miRoncol Health is pleased to announce the appointment of Dr, Christopher M. Gallagher as its new Chief Medical Officer, effective January, 2025. Dr.…
Read More »January 8, 2025
What You Should Know:
Read More »October 16, 2024
In a significant advancement for cancer detection, miRoncol, a medtech startup, has completed proof-of-concept studies for a groundbreaking blood test…
Read More »October 15, 2024
Congratulations to miRoncol, which received a 2024 Breakthrough Merit and Abstract Award for its Abstract Presentation entitled: “Machine…
Read More »August 2, 2024
miRoncol Health appointed Victoria Xu as Chief Executive Officer, effective April 2024.
Read More »April 2024
miRoncol established its Business Advisory Board in April 2024 to provide strategic guidance for its multi-cancer early detection mission.
Read More »April 2024
miRoncol established its Scientific Advisory Board in October 2023, bringing together leading experts to guide its multi-cancer early detection mission.
Read More »October 2023
The world’s first published miRNA based MCED.
Read More »March 11, 2022
Press coverage, conferences, summits, and showcases miRoncol takes part in.
Imagine if a simple blood test could check for early signs of cancer – for several common cancers all at the same time. If that test came back positive…
Read More »November 10, 2025
From the Investor Seat to the Founder’s Booth: Victoria’s SAAS NORTH Evolution.For years, miRoncol Health’s CEO, Victoria Xu, has attended SAAS NORTH…
Read More »November 5, 2025
“Elevate Festival is uniquely Canadian”
Read More »October 7, 2025
miRoncol Health eagerly announces its attendance at the exclusive Archangel Network of Funds Open House on September 10, held during Waterloo Tech Week…
Read More »September 11, 2025
miRoncol Health was honored and delighted to host a booth at OCI DiscoveryX on April 16–17, 2025, in Toronto! We truly enjoyed connecting with fellow…
Read More »April 17, 2025
miRoncol Health is pleased to share its attendance and presentation at Venture Summit West, held April 2–3, 2025, in Mountain View, CA. This highly…
Read More »April 3, 2025
miRoncol Health was delighted to present at the 2025 OBIO Investment Summit, a premier event for the Canadian life sciences, healthcare, and innovation…
Read More »February 7, 2025
miRoncol Health Shines at CHEO Bear’s Den 2024 Innovation Pitch Competition!
Read More »November 20, 2024
We are thrilled to announce that the miRoncol team attended the prestigious MedTech 2024 Conference in Toronto! This gathering was a critical global…
Read More »October 17, 2024
We are excited to inform you that the miRoncol team was selected to present at the high-impact New York Venture Summit in September 2024! Hosted by…
Read More »September 5, 2024
miRoncol’s poster presentation was accepted by the European Society for Medical Oncology (ESMO) Congress 2023. The ESMO Congress is a very important…
Read More »October 15, 2023
We are delighted to share that miRoncol presented groundbreaking work at the 2022 American Association for Cancer Research Annual Meeting. Our poster,…
Read More »April 14, 2022
We are thrilled to announce that miRoncol’s featured presentation at the World Lung Cancer Oral Presentation on September 9, 2021, unveiled a…
Read More »September 9, 2021